Julie Roignot

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury”.

A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury

Cell Reports Medicine(2020)10.1016/j.xcrm.2020.100137

N/A

0DataRank · unranked

72 citations

Eriene-Heidi Sidhom, Abhigyan Satyam, Brian T. Chamberlain, Moran Dvela‐Levitt, Michelle Melanson +31 more

A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.30.180380

N/A

0DataRank · unranked

13 citations

Eriene-Heidi Sidhom, Abhigyan Satyam, Moran Dvela‐Levitt, Michelle Melanson, Brian T. Chamberlain +30 more